Buyon Jill P, Kim Mimi Y, Guerra Marta M, Lu Sifan, Reeves Emily, Petri Michelle, Laskin Carl A, Lockshin Michael D, Sammaritano Lisa R, Branch D Ware, Porter T Flint, Sawitzke Allen, Merrill Joan T, Stephenson Mary D, Cohn Elisabeth, Salmon Jane E
Due to the number of contributing authors, the affiliations are provided in the Supplemental Material .
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.
Kidney disease is a critical concern in counseling patients with lupus considering pregnancy. This study sought to assess the risk of renal flares during pregnancy in women with previous lupus nephritis in partial or complete remission, particularly in those with antidouble-stranded DNA antibodies and low complement levels, and the risk of new-onset nephritis in patients with stable/mildly active SLE.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assessed active nephritis (renal flares and kidney disease) and associated predictors during pregnancy in patients with lupus with urine protein ≤1000 mg and serum creatinine <1.2 mg/dl at baseline; 373 patients (52% ethnic/racial minorities) enrolled between 2003 and 2012 were prospectively followed in the Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Syndrome and Systemic Lupus Erythematosus Study. Active nephritis was defined by proteinuria increase of >500 mg and/or red blood cell casts.
Of 118 patients with previous kidney disease, 13 renal flares (11%) occurred (seven of 89 in complete remission and six of 29 in partial remission) compared with four with kidney involvement (2%) in 255 patients without past kidney disease (<0.001). Active nephritis was not associated with ethnicity, race, age, creatinine, BP, or antihypertensive and other medications. In multivariable logistic regression analyses, patients with past kidney disease in complete or partial remission more often experienced active nephritis (adjusted odds ratio, 6.88; 95% confidence interval, 1.84 to 25.71; =0.004 and adjusted odds ratio, 20.98; 95% confidence interval, 4.69 to 93.98; <0.001, respectively) than those without past kidney disease. Low C4 was associated with renal flares/ disease (adjusted odds ratio, 5.59; 95% confidence interval, 1.64 to 19.13; <0.01) but not low C3 or positive anti-dsDNA alone.
kidney involvement in SLE, even in ethnic/racial minorities, is uncommon during pregnancy. Past kidney disease and low C4 at baseline independently associate with higher risk of developing active nephritis. Antibodies to dsDNA alone should not raise concern, even in patients with past kidney disease, if in remission.
在为狼疮患者提供妊娠咨询时,肾脏疾病是一个关键问题。本研究旨在评估既往狼疮性肾炎部分或完全缓解的女性在妊娠期间发生肾脏活动的风险,尤其是那些抗双链DNA抗体阳性且补体水平低的患者,以及稳定/轻度活动的系统性红斑狼疮(SLE)患者发生新发肾炎的风险。
设计、地点、参与者及测量方法:我们评估了基线时尿蛋白≤1000mg且血清肌酐<1.2mg/dl的狼疮患者在妊娠期间的活动性肾炎(肾脏活动和肾脏疾病)及相关预测因素;2003年至2012年期间纳入的373例患者(52%为少数族裔/种族)在“妊娠结局预测:抗磷脂综合征和系统性红斑狼疮中的生物标志物研究”中进行了前瞻性随访。活动性肾炎的定义为蛋白尿增加>500mg和/或红细胞管型。
118例既往有肾脏疾病的患者中,发生了13次肾脏活动(11%)(完全缓解的89例中有7例,部分缓解的29例中有6例),而255例无既往肾脏疾病的患者中有4例出现肾脏受累(2%)(P<0.001)。活动性肾炎与种族、年龄、肌酐、血压或抗高血压药物及其他药物无关。在多变量逻辑回归分析中,既往有肾脏疾病且处于完全或部分缓解状态的患者比无既往肾脏疾病的患者更常发生活动性肾炎(调整后的优势比分别为6.88;95%置信区间为1.84至25.71;P=0.004和调整后的优势比为20.98;95%置信区间为4.69至93.98;P<0.001)。低C4与肾脏活动/疾病相关(调整后的优势比为5.59;95%置信区间为1.64至19.13;P<0.01),但单独的低C3或抗双链DNA阳性则无此关联。
即使在少数族裔/种族中,SLE患者在妊娠期间肾脏受累也不常见。既往肾脏疾病和基线时低C4独立地与发生活动性肾炎的较高风险相关。即使是既往有肾脏疾病的患者,若处于缓解状态,单独的双链DNA抗体阳性也无需担忧。